Essais liés2clinical trials
VilleLillelocalisation
PaysFrancelocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT03900221

Ouvrir le site du centre

Essais cliniques associés

2
MoléculeIndication / populationPhaseNCTTitreStatut
Tys at Home — Comparing the Safety and Benefit of Natalizumab (Tysabri®) At-home Infusion vs At-hospital Infusion in Multiple Sclerosis SEP À vérifier NCT04777539 Tys at Home — Comparing the Safety and Benefit of Natalizumab (Tysabri®) At-home Infusion vs At-hospital Infusion in Multiple Sclerosis COMPLETED
RESPONSE — French Registry for Monitoring Pregnancies for Multiple Sclerosis SEP À vérifier NCT03900221 RESPONSE — French Registry for Monitoring Pregnancies for Multiple Sclerosis RECRUITING